2024-11-19 21:32:20
Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy
Corporate/ 2023-07-24
Alterity Therapeutics Doses First Patien...

MELBOURNE,Australia and SAN FRANCISCO,July 6,2022-- Alterity Therapeutics (ASX: ATH,NASDAQ: ATHE) ("Alterity" or "the Company...

WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility
Corporate/ 2023-07-24
WuXi STA Opens New Large-scale Oligonucl...

Site Enhances New Modality CRDMO Platform Capacity for Customers SHANGHAI,July 7,2022-- WuXi STA,a subsidiary of WuXi AppTec,today announced...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release